Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olysio in HCV Genotype-1 and HIV-1 Co-infection
NCT01479868Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Oct 2011
- Primary completion
- Aug 2013
- Modality
- Reversible Covalent Inhibitors, Allosteric Modulators, Orthosteric Ligands
- Countries
- 8
01
Overview
A Phase 3 trial of simeprevir in Hepatitis C genotype 1, sponsored by Janssen Pharmaceutical. Started Oct 2011; status: completed.
02
Drugs
simeprevir
03
Conditions
Hepatitis C genotype 1
Beyond the preview
Go deeper on NCT01479868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01479868.